• Users Online: 412
  • Print this page
  • Email this page

    Article Cited by others


Corticosteroids for diabetic macular edema

Chawan-Saad Jorge, Wu Max, Wu Andres, Wu Lihteh

Year : 2019| Volume: 9| Issue : 4 | Page no: 233-242

   This article has been cited by
1 The 0.19-mg Fluocinolone Acetonide Intravitreal Implant Reduces Treatment Burden in Diabetic Macular Edema
Pauline T. Merrill, Nancy Holekamp, Daniel Roth, Jonathan Kasper, Ruben Grigorian
American Journal of Ophthalmology. 2023; 248: 16
[Pubmed]  [Google Scholar] [DOI]
2 Vitreous humor proteome: unraveling the molecular mechanisms underlying proliferative and neovascular vitreoretinal diseases
Fátima Milhano dos Santos, Sergio Ciordia, Joana Mesquita, João Paulo Castro de Sousa, Alberto Paradela, Cândida Teixeira Tomaz, Luís António Paulino Passarinha
Cellular and Molecular Life Sciences. 2023; 80(1)
[Pubmed]  [Google Scholar] [DOI]
3 Diabetic Macular Oedema Guidelines: An Australian Perspective
Yew Sen Yuen, Jagjit Singh Gilhotra, Michelle Dalton, Jaskirat S. Aujla, Hemal Mehta, Sanj Wickremasinghe, Gurmit Uppal, Jennifer Arnold, Fred Chen, Andrew Chang, Samantha Fraser-Bell, Lyndell Lim, Janika Shah, Ellie Bowditch, Geoffrey K. Broadhead, Paolo Milani
Journal of Ophthalmology. 2023; 2023: 1
[Pubmed]  [Google Scholar] [DOI]
4 The 0.19-mg Fluocinolone Acetonide Implant for the Treatment of Diabetic Macular Edema: An Expert Consensus
Anton M. Kolomeyer, David A. Eichenbaum, Daniel F. Kiernan, Ivan J. Suñer, Seenu M. Hariprasad
Ophthalmic Surgery, Lasers and Imaging Retina. 2023; 54(3): 166
[Pubmed]  [Google Scholar] [DOI]
5 Retinal Diseases: The Next Frontier in Pharmacodelivery
Assaf Ben-Arzi, Rita Ehrlich, Ron Neumann
Pharmaceutics. 2022; 14(5): 904
[Pubmed]  [Google Scholar] [DOI]
6 Dexamethasone suppresses the proliferation and migration of VSMCs by FAK in high glucose conditions
Ali Akbar Soleimani, Asghar Mohammadi, Ghasem Ghasempour, Borhan Rahimi Abkenar, Nafiseh Shokri, Mohammad Najafi
BMC Pharmacology and Toxicology. 2022; 23(1)
[Pubmed]  [Google Scholar] [DOI]
7 Drugs associated with cataract formation represent an unmet need in cataract research
Jack Carlson, Kate McBride, Michael O’Connor
Frontiers in Medicine. 2022; 9
[Pubmed]  [Google Scholar] [DOI]
8 Current and Novel Therapeutic Approaches for Treatment of Diabetic Macular Edema
Muhammad Z. Chauhan, Peyton A. Rather, Sajida M. Samarah, Abdelrahman M. Elhusseiny, Ahmed B. Sallam
Cells. 2022; 11(12): 1950
[Pubmed]  [Google Scholar] [DOI]
9 The Role of Intravitreal Corticosteroids in the Treatment of DME: Predictive OCT Biomarkers
Marion R. Munk, Gabor Mark Somfai, Marc D. de Smet, Guy Donati, Marcel N. Menke, Justus G. Garweg, Lala Ceklic
International Journal of Molecular Sciences. 2022; 23(14): 7585
[Pubmed]  [Google Scholar] [DOI]
10 Real-Life Efficacy, Safety, and Use of Dexamethasone Intravitreal Implant in Posterior Segment Inflammation Due to Non-infectious Uveitis (LOUVRE 2 Study)
Bahram Bodaghi, Antoine P. Brézin, Michel Weber, Cécile Delcourt, Laurent Kodjikian, Alexandra Provost, Marie-Ève Velard, Doris Barnier-Ripet, Sybil Pinchinat, Laure Dupont-Benjamin
Ophthalmology and Therapy. 2022;
[Pubmed]  [Google Scholar] [DOI]
11 Management of Diabetic Macular Edema: Guidelines from the Emirates Society of Ophthalmology
Noura Al Qassimi, Igor Kozak, Maysoon Al Karam, Piergiorgio Neri, Patricio M. Aduriz-Lorenzo, Alaa Attawan, Mohamed Awadalla, Ahmed El Khashab, Mohamed Abdul-Nabi, Ammar Safar, Hanan Al Shamsi, Prasan Rao, Madhav Rao, Amr Farid, Avinash Gurbaxani
Ophthalmology and Therapy. 2022;
[Pubmed]  [Google Scholar] [DOI]
12 Newer therapeutic agents for retinal diseases
Ashish Markan, Swechya Neupane, Rupesh Agrawal, Vishali Gupta
Expert Review of Ophthalmology. 2022; : 1
[Pubmed]  [Google Scholar] [DOI]
13 Intravitreal steroids compared to anti-vascular endothelial growth factor treatment for diabetic macular edema: a meta-analysis
Nikhil S. Patil, Andrew Mihalache, Amin Hatamnejad, Marko M. Popovic, Peter J. Kertes, Rajeev H. Muni
Ophthalmology Retina. 2022;
[Pubmed]  [Google Scholar] [DOI]
14 Studies of the retinal microcirculation using human donor eyes and high-resolution clinical imaging: Insights gained to guide future research in diabetic retinopathy
Chandrakumar Balaratnasingam, Dong An, Martin Hein, Paula Yu, Dao-Yi Yu
Progress in Retinal and Eye Research. 2022; : 101134
[Pubmed]  [Google Scholar] [DOI]
15 Primary cilia in retinal pigment epithelium development and diseases
Chunjiao Sun,Jun Zhou,Xiaoqian Meng
Journal of Cellular and Molecular Medicine. 2021;
[Pubmed]  [Google Scholar] [DOI]
16 Long-term outcomes of administration of intravitreal triamcinolone acetonide after posterior vitreous detachment during pars plana vitrectomy for proliferative diabetic retinopathy
Mengyu Liao, Yunli Huang, Jiaxing Wang, Xiangda Meng, Yuanyuan Liu, Jinguo Yu, Hua Yan
British Journal of Ophthalmology. 2021; : bjophthalm
[Pubmed]  [Google Scholar] [DOI]
17 Ultrasound and Microbubbles for the Treatment of Ocular Diseases: From Preclinical Research towards Clinical Application
Charis Rousou, Carl C. L. Schuurmans, Arto Urtti, Enrico Mastrobattista, Gert Storm, Chrit Moonen, Kai Kaarniranta, Roel Deckers
Pharmaceutics. 2021; 13(11): 1782
[Pubmed]  [Google Scholar] [DOI]
18 Anti-inflammatory Effect of Curcumin, Homotaurine, and Vitamin D3 on Human Vitreous in Patients With Diabetic Retinopathy
Mariaelena Filippelli,Giuseppe Campagna,Pasquale Vito,Tiziana Zotti,Luca Ventre,Michele Rinaldi,Silvia Bartollino,Roberto dellæOmo,Ciro Costagliola
Frontiers in Neurology. 2021; 11
[Pubmed]  [Google Scholar] [DOI]
19 Rho-Kinase Inhibitors for the Treatment of Refractory Diabetic Macular Oedema
Milagros Mateos-Olivares,Luis García-Onrubia,Fco. Javier Valentín-Bravo,Rogelio González-Sarmiento,Maribel Lopez-Galvez,J. Carlos Pastor,Ricardo Usategui-Martín,Salvador Pastor-Idoate
Cells. 2021; 10(7): 1683
[Pubmed]  [Google Scholar] [DOI]
20 Efficacy of intravitreal dexamethasone implant as a starting monotherapy and when switching from an anti-VEGF drug in diabetic macular edema
M.M. Bikbov, R.M. Zainullin, K.I. Kudoyarova, M.R. Kalanov
Vestnik oftal'mologii. 2021; 138(6): 5
[Pubmed]  [Google Scholar] [DOI]
21 Early treatment with dexamethasone intravitreal implants in diabetic macular edema: Naïve versus refractory patients
Anna V Bux, Francesca Fortunato, Antonio Barone, Vincenzo Russo, Nicola Delle Noci, Cristiana Iaculli
European Journal of Ophthalmology. 2021; : 1120672121
[Pubmed]  [Google Scholar] [DOI]
22 Guidelines for the Management of Center-Involving Diabetic Macular Edema: Treatment Options and Patient Monitorization
João Figueira,José Henriques,Ângela Carneiro,Carlos Marques-Neves,Rita Flores,João Paulo Castro-Sousa,Angelina Meireles,Nuno Gomes,João Nascimento,Miguel Amaro,Rufino Silva
Clinical Ophthalmology. 2021; Volume 15: 3221
[Pubmed]  [Google Scholar] [DOI]

Rapid Structural and Functional Improvements with the 0.19 mg Fluocinolone Acetonide Intravitreal Implant for Patients with DME and Low Visual Acuity: 6-Month Data from the UAE

Ahmed Mohammed Elbarky
Clinical Ophthalmology. 2020; Volume 14: 823
[Pubmed]  [Google Scholar] [DOI]
24 Anterior Migration of Triamcinolone Acetonide after Posterior Subtenon Injection for Macular Edema Predisposes to Intraocular Pressure Elevation
Yun-Hsiang Yang,Wei-Cherng Hsu,Yi-Ting Hsieh
Current Eye Research. 2020; : 1
[Pubmed]  [Google Scholar] [DOI]


Read this article